allergan irvine

Allergan: atogepant

Allergan looks set to be a latecomer to the calcitonin gene-related peptide antagonist class of migraine prevention drugs, but its late-stage candidate—atogepant—is trying to become the first oral alternative to the current crop of injectable drugs in the class.